Durvalumab, Cediranib ± Olaparib in Recurrent Ovarian Cancer
In a groundbreaking phase II proof-of-concept clinical trial published recently in Nature Communications, researchers led by Tabata, Huang, and Giudice ...
Tag: immune checkpoint inhibitors PD-L1
NRG Oncology/Alliance Study Shows Adding Immunotherapy to Chemoradiotherapy Fails to Extend Survival in Small Cell Lung Cancer
In the evolving landscape of oncology, a pivotal international phase III clinical trial—NRG-LU005—has recently reshaped the understanding of treatment paradigms ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!